EBMT
Eagle Bancorp Montana, Inc.
EBMT has a slight edge over JPM overall, supported by stronger valuation.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
EBMT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
EBMT's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like EBMT.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
EBMT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.8x | $15.45 | -25% |
| Forward | 9x | $20.61 | — |
| Fair | 10x | $20.77 | +0.8% |
| Current | 10x | $20.61 | — |
| Expensive | 13x | $24.90 | +21% |
Historical ranges are pointers, not guarantees.
EBMT has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
EBMT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
EBMT has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
EBMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +16% |
| Q3 2026 | $1.98 | +15% |
| Q2 2026 | $2.06 | +29% |
| Q1 2026 | $2.00 | +42% |
| Q4 2025 | $1.90 | +53% |
| Q3 2025 | $1.72 | +61% |
| Q2 2025 | $1.60 | +50% |
| Q1 2025 | $1.41 | +27% |
| Q4 2024 | $1.24 | -3.9% |
EBMT's earnings per share have fallen from their peak: $1.98 over the past year, against $3.32 in early 2021.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
EBMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.1M | +7.2% |
| Q2 2026 | $24.2M | +5.2% |
| Q1 2026 | $23.6M | +13% |
| Q4 2025 | $24.3M | +14% |
| Q3 2025 | $23.4M | +13% |
| Q2 2025 | $23M | +15% |
| Q1 2025 | $20.9M | +9.1% |
| Q4 2024 | $21.4M | +1.7% |
EBMT has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | -5.8 points |
| Q2 2026 | 20% | +2.6 points |
| Q1 2026 | 22% | +3.1 points |
| Q4 2025 | 25% | +7.7 points |
| Q3 2025 | 21% | +5.6 points |
| Q2 2025 | 17% | +6.4 points |
| Q1 2025 | 19% | +6.7 points |
| Q4 2024 | 17% | +8.5 points |
EBMT's operating margin was 15% last quarter, down 5.8 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over EBMT on profitability, with a higher operating margin.
EBMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.5M | +34% |
| Q2 2026 | -$2.8M | -301% |
| Q1 2026 | -$5.2M | -2079% |
| Q4 2025 | $19.6M | +60% |
| Q3 2025 | $7.1M | +$7.8M |
| Q2 2025 | $1.4M | +121% |
| Q1 2025 | $262K | -89% |
| Q4 2024 | $12.2M | +27% |
EBMT has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
EBMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +11.5K shares |
| 1 year | +0.6% | +45.4K shares |
| 3 years | +1.1% | +82K shares |
| 5 years | +20% | +1.3M shares |
| Available history | +22% | +1.4M shares |
EBMT has 8M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $410,000 |
| Q3 2025 | — |
| Q2 2025 | $408,000 |
| Q1 2025 | $755,000 |
| Q4 2024 | $419,000 |
EBMT spent $410,000 buying back its own shares over the past year, down 74% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over EBMT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
EBMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.5x | Healthy |
EBMT's net debt is less than a year of its operating earnings (EBITDA), down from 1.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like EBMT.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over EBMT on leverage, with a lower net debt burden relative to earnings.
EBMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.8 | Neutral |
| Stochastic | 18.6 | Oversold |
EBMT's weekly RSI is 39 (neutral) and its Stochastic is 19 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
EBMT PE vs Financial Services Sector
| Metric | EBMT | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 20% below |
| PE % | 48 | 63 | 15 pts below |
EBMT has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
EBMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.0 | 1.9% below |
| 20 week MA | $22.3 | 7.4% below |
| 50 week MA | $21.8 | 5.4% below |
| 100 week MA | $19.2 | 7.5% above |
| 200 week MA | $16.6 | 24% above |
EBMT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 24% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over EBMT on trend strength, trading above more of its moving averages.
EBMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.1 | $21.9 | +3.8% |
| 2021 | $21.9 | $22.9 | +4.7% |
| 2022 | $22.9 | $16.2 | -29% |
| 2023 | $16.2 | $15.8 | -2.4% |
| 2024 | $15.8 | $15.3 | -3.4% |
| 2025 | $15.3 | $19.8 | +30% |
| 2026 YTD | $19.8 | $20.6 | +4.2% |
EBMT has finished lower in three of the last six years. It's up 4.2% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over EBMT on returns for 2026, with the stronger performance.